These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4599855)

  • 41. Comparison of the responses of Escherichia coli and proteus mirabilis to seven beta-lactam antibodies.
    Greenwood D; O'Grady F
    J Infect Dis; 1973 Aug; 128(2):211-22. PubMed ID: 4579140
    [No Abstract]   [Full Text] [Related]  

  • 42. Imipenem resistance in clinical isolates of Proteus mirabilis associated with alterations in penicillin-binding proteins.
    Neuwirth C; Siébor E; Duez JM; Péchinot A; Kazmierczak A
    J Antimicrob Chemother; 1995 Aug; 36(2):335-42. PubMed ID: 8522463
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Complex Co1E1 DNA in Escherichia coli and Proteus mirabilis.
    Goebel W; Kreft J
    Mol Gen Genet; 1974 Mar; 129(2):149-66. PubMed ID: 4598797
    [No Abstract]   [Full Text] [Related]  

  • 44. Alternate forms of the resistance factor R1 in Proteus mirabilis.
    Meyer R
    J Bacteriol; 1974 Jun; 118(3):1010-9. PubMed ID: 4597993
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Potent combinations of beta-lactam antibiotics using the beta-lactamase inhibition principle.
    Greenwood D; O'Grady F
    Chemotherapy; 1975; 21(6):330-41. PubMed ID: 1102266
    [TBL] [Abstract][Full Text] [Related]  

  • 46. R factors from Proteus mirabilis and P. vulgaris.
    Hedges RW
    J Gen Microbiol; 1975 Apr; 87(2):301-11. PubMed ID: 1095684
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Emerging bacterial pathogens: Escherichia coli, Enterobacter aerogenes and Proteus mirabilis clinical isolates harbouring the same transferable plasmid coding for metallo-beta-lactamase VIM-1 in Greece.
    Galani I; Souli M; Koratzanis E; Koratzanis G; Chryssouli Z; Giamarellou H
    J Antimicrob Chemother; 2007 Mar; 59(3):578-9. PubMed ID: 17255145
    [No Abstract]   [Full Text] [Related]  

  • 48. [Resistance of clinical strains of Proteus to various beta-lactam antibiotics].
    Shvidenko IG
    Antibiotiki; 1976 Oct; 21(10):910-4. PubMed ID: 793508
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Derivation of a Proteus mirabilis converting phage for ampicillin resistance.
    Coetzee JN
    J Gen Microbiol; 1977 Mar; 99(1):127-38. PubMed ID: 325175
    [No Abstract]   [Full Text] [Related]  

  • 50. Curing action of sodium dodecyl sulfate on a Proteus mirabilis R+ strain.
    Tomoeda M; Inuzuka M; Anto S; Konishi M
    J Bacteriol; 1974 Dec; 120(3):1158-63. PubMed ID: 4140184
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Development of resistance to ampicillin in gram negative microorganisms in vitro].
    Braginskaia PS; Shneerson AN; Rezvan SP
    Antibiotiki; 1969 Sep; 14(9):831-4. PubMed ID: 4982965
    [No Abstract]   [Full Text] [Related]  

  • 52. A carbenicillin R factor from Pseudomonas aeruginosa.
    van Rensburg AJ; de Kock MJ
    S Afr Med J; 1974 Jun; 48(28):1187-90. PubMed ID: 4209641
    [No Abstract]   [Full Text] [Related]  

  • 53. Prevalence and resistance patterns of extended-spectrum and AmpC β-lactamase in Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, and Salmonella serovar Stanley in a Korean tertiary hospital.
    Park SD; Uh Y; Lee G; Lim K; Kim JB; Jeong SH
    APMIS; 2010 Oct; 118(10):801-8. PubMed ID: 20854475
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bacteriological and clinical evaluation of the combination of cloxacillin with ampicillin.
    Klastersky J; Debusscher L; Rühl D
    Chemotherapy; 1972; 17(6):382-91. PubMed ID: 4628324
    [No Abstract]   [Full Text] [Related]  

  • 55. [Bactericidal activity of amoxicillin. In vitro bactericidal activity and therapeutic effect for experimental infections (author's transl)].
    Kamimura T; Okada N; Matsumoto Y; Nishida M
    Jpn J Antibiot; 1979 Mar; 32(3):364-8. PubMed ID: 374774
    [No Abstract]   [Full Text] [Related]  

  • 56. A transmissible resistance element from a strain of Pseudomonas aeruginosa containing no detectable extrachromosomal DNA.
    Ingram L; Sykes RB; Grinsted J; Saunders JR; Richmond MH
    J Gen Microbiol; 1972 Sep; 72(2):269-79. PubMed ID: 4627884
    [No Abstract]   [Full Text] [Related]  

  • 57. Extended-spectrum beta-lactamase in Proteus mirabilis.
    Mariotte S; Nordmann P; Nicolas MH
    J Antimicrob Chemother; 1994 May; 33(5):925-35. PubMed ID: 8089066
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular specificities of R factor-determined beta-lactamases: correlation with plasmid compatibility.
    Hedges RW; Datta N; Kontomichalou P; Smith JT
    J Bacteriol; 1974 Jan; 117(1):56-62. PubMed ID: 4587613
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Penicillin-binding proteins in Proteus species.
    Ohya S; Yamazaki M; Sugawara S; Matsuhashi M
    J Bacteriol; 1979 Jan; 137(1):474-9. PubMed ID: 368025
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High frequency transduction of kanamycin resistance in Proteus mirabilis.
    Coetzee JN
    J Gen Microbiol; 1974 Oct; 84(2):285-96. PubMed ID: 4615126
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.